Sanara MedTech Inc. Financials

Market Capitalization $263.5 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE	55.36
Price to Sales TTM	$4.11
Price to Book MRQ	$5.90
Enterprise to Revenue	4.21
Enterprise to EBITDA	-68.62

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	-6.62%
Operating Margin	-12.33%
Return on Assets TTM	-7.10%
Return on Equity TTM	-10.29%

Income Statement

Revenue TTM	$64,989,840
Revenue per Share TTM	$7.85
Quarterly Revenue Growth	15.50%
Gross Profit TTM	$57,137,156
EBITDA	$-3,990,022
Net Income to Common TTM	$-4,303,197
Diluted EPS TTM	$-0.52
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$5,147,216
Total Cash per Share MRQ	$0.60
Total Debt MRQ	$
Total Debt to Equity MRQ	26.45
Current Ratio MRQ	1.38
Book Value per Share MRQ	$5.25

Cash Flow

Operating Cash Flow TTM	$-3,245,556
Levered Free Cash Flow TTM	$-97,559

SMTI Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	8,622,800
Float Shares	3,454,554
Avg 10 Volume	9,450
Avg 30 Volume	None
Shares Short	140,254
Short Ratio	10.09
Short % of Shares	25.91%
% Held by Insiders	60.07%
% Held by Institutions	8.39%

Stock Price Summary

Beta	1.63
Fifty Two Week Low	$26.06
Fifty Two Week High	$46.40
Fifty Two Week Change	-17.91%
Day 50 MA	$35.27
Day 200 MA	$35.50

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2019-05-10
Ex Dividend Date
Last Split Factor
Last Split Date	2019-05-10